Login

Pierre Laurin, CEO, ProMetic Life Sciences Inc 00:00:00

Share On Facebook Share On Twitter

Pierre Laurin of ProMetic gives a summary of the company's drug development platform

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Revisiting Addiction: Beyond Medicalization|Dr. Sally Satel,Professor,American Enterprise Institute
00:10:00
Thasunda Brown Duckett: A Journey of Resilience and Leadership | Thasunda Brown Duckett, CEO , TIAA.
00:10:00
How Engine Biosciences integrates machine learning, high-throughput biological experimentation, and innovative chemistry to decipher biology and develop new medicines for patients|Jeffrey Lu , CEO OF ENGINE BIOSCIENCES
00:10:00
Top 3 Investment Tips: Diversification, Company Understanding, and Valuation
00:10:00
Unveiling Norseman: A Glimpse into Fiercely Reliable Fabric Buildings | Ron Bryant - CEO at Norseman
00:10:00
Alzheimer's Disease Solutions | Remi Barbier, CEO, Cassava Sciences Inc.
00:10:00
Expert Insights: Why Buyers and Sellers Should Involve Real Estate Attorneys Early in Transactions
00:10:00
Expanding Robotic Solutions for Neurological Rehabilitation: Innovations and Growth Plans
00:10:00
QuestEx: Advancing Exploration in Northern BC's Golden Triangle
00:10:00
Appian CEO Delivering ‘Mission-Critical’ Software | Matt Calkins, CEO, Appian CorpAPPN:NMQ
00:10:00
Richard Salmen Joins FIC: Elevating Financial Freedom in 2018 | Dan Danford - FOUNDER AND CHAIRMAN OF THE BOARD of Family Investment Center
00:10:00
Global Growth and Strategic Success: Banco Santander's Strong Start to 2023 | Hector Grisi , CEO , Banco Santander.

© 2017 - Neuhu+